Proactive Vs Reactive Therapeutic Drug Monitoring of Infliximab in Crohn's Disease: A Cost-Effectiveness Analysis in a Simulated Cohort
about
Proactive Vs Reactive Therapeutic Drug Monitoring of Infliximab in Crohn's Disease: A Cost-Effectiveness Analysis in a Simulated Cohort
description
im Jahr 2020 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 January 2020
@en
name
Proactive Vs Reactive Therapeu ...... Analysis in a Simulated Cohort
@en
type
label
Proactive Vs Reactive Therapeu ...... Analysis in a Simulated Cohort
@en
prefLabel
Proactive Vs Reactive Therapeu ...... Analysis in a Simulated Cohort
@en
P2093
P356
P1476
Proactive Vs Reactive Therapeu ...... Analysis in a Simulated Cohort
@en
P2093
Adam S Cheifetz
Bonnie Baumgartner
Brooke Swanhorst
Diana M Negoescu
James P Campbell
Konstantinos Papamichael
Mark T Osterman
P304
P356
10.1093/IBD/IZZ113
P577
2020-01-01T00:00:00Z